Auteur J. M. CORKERY

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

2-DPMP (desoxypipradrol, 2-benzhydrylpiperidine, 2-phenylmethylpiperidine) and D2PM (diphenyl-2-pyrrolidin-2-yl-methanol, diphenylprolinol): A preliminary review

J. M. CORKERY ; S. ELLIOTT ; F. SCHIFANO ; O. CORAZZA ; A. H. GHODSE | 2012
Dans Progress in Neuro-Psychopharmacology and Biological Psychiatry (Vol.39, n°2, 3 December 2012) Article : Périodique

2-DPMP (desoxypipradrol, 2-benzhydrylpiperidine, 2-phenylmethylpiperidine) and D2PM (diphenyl-2-pyrrolidin-2-yl-methanol, diphenylprolinol) are psychoactive substances, sold primarily over the Internet and in 'head' shops as 'legal highs', 'rese[...]

Plus d'info

Ajouter à la sélection

5,6-Methylenedioxy-2-aminoindane: from laboratory curiosity to 'legal high'

C. T. GALLAGHER ; S. ASSI ; J. L. STAIR ; S. FERGUS ; O. CORAZZA ; J. M. CORKERY ; F. SCHIFANO | 2012
Dans Human Psychopharmacology: Clinical and Experimental (Vol.27, n°2, March 2012) Article : Périodique

OBJECTIVES: The fully synthetic 'legal high' 5,6-methylenedioxy-2-aminoindane (MDAI) is an analogue of 3,4-methylenedioxymethamphetamine. Although developed in the 1990s, it was not widely abused until 2010. However, mephedrone was banned in the[...]

Plus d'info

Ajouter à la sélection

An exploratory study of information sources and key findings on UK cocaine-related deaths

J. M. CORKERY ; H. CLARIDGE ; C. GOODAIR ; F. SCHIFANO | 2017
Dans Journal of Psychopharmacology (Vol.31, n°8, August 2017) Article : Périodique

Cocaine-related deaths have increased since the early 1990s in Europe, including the UK. Being multi-factorial, they are difficult to define, detect and record. The European Monitoring Centre for Drugs and Drug Addiction commissioned research to[...]

Plus d'info

Ajouter à la sélection

Cocaine-related health emergencies in Europe: a review of sources of information, trends and implications for service development

G. MENA ; I. GIRAUDON ; E. ALVAREZ ; J. M. CORKERY ; J. MATIAS ; K. GRASAASEN ; N. LLORENS ; P. GRIFFITHS ; J. VICENTE | 2013
Dans European Addiction Research (Vol.19, n°2, February 2013) Article : Périodique

Background: Cocaine-related health consequences are difficult to observe. Data on drug users in health-emergency settings may be a useful source of information on consequences that are not visible via other information sources. Methods: Thirty[...]

Plus d'info

Ajouter à la sélection

Lien externe

Deaths of individuals aged 16-24 years in the UK after using mephedrone

B. LOI ; J. M. CORKERY ; H. CLARIDGE ; C. GOODAIR ; S. CHIAPPINI ; C. GIMENO CLEMENTE ; F. SCHIFANO | 2015
Dans Human Psychopharmacology: Clinical and Experimental (Vol.30, n°4, July 2015) Article : Périodique

Objective: Mephedrone is a stimulant drug chemically related to amphetamine, with effects similar to those of amphetamine and cocaine. This study aims to analyse fatalities following ingestion of mephedrone in the UK amongst 16- to 24-year-olds [...]

Plus d'info

Ajouter à la sélection

How deaths can help clinicians and policy-makers understand the risks of novel psychoactive substances

J. M. CORKERY ; F. SCHIFANO ; G. MARTINOTTI | 2020
Dans British Journal of Clinical Pharmacology (Vol.86, n°3, March 2020) Article : Périodique

Novel psychoactive substances (NPS), especially those newly created, are largely an unknown quantity, particularly in terms of their potential serious adverse effects. This means that policy-makers and clinicians are under-informed about appropr[...]

Plus d'info

Ajouter à la sélection

Lien externe

Identifying new/emerging psychoactive substances at the time of COVID-19; A web-based approach

V. CATALANI ; D. ARILLOTTA ; J. M. CORKERY ; A. GUIRGUIS ; A. VENTO ; F. SCHIFANO | 2021
Dans Frontiers in Psychiatry (Vol.11, 2021) Article : Périodique

COVID-19-related disruptions of people and goods' circulation can affect drug markets, especially for new psychoactive substances (NPSs). Drug shortages could cause a change in available NPS, with the introduction of new, unknown, substances. Th[...]

Plus d'info

Ajouter à la sélection

Lien externe

Mephedrone-related fatalities in the United Kingdom: Contextual, clinical and practical issues, pharmacology

J. M. CORKERY, Auteur ; F. SCHIFANO, Auteur ; A. H. GHODSE, Auteur ; L. GALLELLI, Éditeur scientifique | 2012
Chapitre

The misuse of mephedrone (4-methylmethcathinone) has been increasing greatly in Western countries over the last two years or so, especially in the club and dance scenes. This period has also been marked by claims that the substance has been impl[...]

Plus d'info

Ajouter à la sélection

Lien externe

Methoxetamine-related deaths in the UK: an overview

S. CHIAPPINI ; H. CLARIDGE ; J. M. CORKERY ; C. GOODAIR ; B. LOI ; F. SCHIFANO | 2015
Dans Human Psychopharmacology: Clinical and Experimental (Vol.30, n°4, July 2015) Article : Périodique

Objective: The goal of this study is to provide an update on the data given on methoxetamine (MXE)-related fatalities that occurred in 2011-2013, presented at the Second International Conference on Novel Psychoactive Substances. Methods: Fatali[...]

Plus d'info

Ajouter à la sélection

Novel opioids: Systematic web crawling within the e-psychonauts' scenario

D. ARILLOTTA ; F. SCHIFANO ; F. NAPOLETANO ; C. ZANGANI ; L. GILGAR ; A. GUIRGUIS ; J. M. CORKERY ; E. AGUGLIA ; A. VENTO | 2020
Dans Frontiers in Neuroscience (Vol.14, 2020) Article : Périodique

Background: A wide range of novel psychoactive substances (NPSs) are regularly searched and discussed online by e-psychonauts. Among NPSs, the range of prescription/non-prescription opioids (fentanyl and non-fentanyl analogs) and herbal derivati[...]

Plus d'info

Ajouter à la sélection

Lien externe

Snowed under : is it the real thing?

J. M. CORKERY | 2000
Périodique

FRANÇAIS : L'auteur fait trois constats: 1) l'usage de la cocaïne et du crack chez les 16-24 ans était constant au Royaume-Uni entre 1994 et 1996, mais a fortement augmenté entre 1996 et 1998. Les morts liées à la cocaïne ont augmenté de 2,5% p[...]

Plus d'info

Ajouter à la sélection

Spice drugs, synthetic cannabinoids, and "Spiceophrenia"

D. PAPANTI ; L. ORSOLINI ; J. M. CORKERY ; F. SCHIFANO | 2019
Chapitre

Plus d'info

Ajouter à la sélection

Synthetic cathinones and related fatalities in the United Kingdom

J. M. CORKERY ; C. GOODAIR ; H. CLARIDGE | 2019
Chapitre

Plus d'info

Ajouter à la sélection

The clinical challenges of synthetic cathinones

F. SCHIFANO ; F. NAPOLETANO ; D. ARILLOTTA ; C. ZANGANI ; L. GILGAR ; A. GUIRGUIS ; J. M. CORKERY ; A. VENTO | 2020
Dans British Journal of Clinical Pharmacology (Vol.86, n°3, March 2020) Article : Périodique

Aims: Within the new psychoactive substances (NPS) scenario, several hundred different molecules, mostly including synthetic cannabinoids and cathinones, have been identified so far. The aims of the paper were to: (i) identify the number of synt[...]

Plus d'info

Ajouter à la sélection

The effects of methadone and its role in fatalities

J. M. CORKERY ; F. SCHIFANO ; A. H. GHODSE ; A. OYEFESO | 2004
Dans Human Psychopharmacology: Clinical and Experimental (Vol.19, n°8, December 2004) Article : Périodique

Methadone is a synthetic opioid, used both as an analgesic in severe pain relief and now mainly in the treatment of opiate dependence. Such use of the drug has increased as its advantages have become widely recognized. There are undesirable outc[...]

Plus d'info

Ajouter à la sélection